V. Bramwell

S. Rosenberg, P. Voûte, V. Bramwell, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Primary Carcinoma of the Fallopian Tube: Favourable Response to New Chemotherapeutic Agent, CHIP

D. Crowther, V. Bramwell, J. Wagstaff, 1985, Journal of the Royal Society of Medicine.

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

J. Crowley, G. Demetri, R. Maki, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant Chemotherapy Following Complete Resection of Soft Tissue Sarcoma in Adults: A Clinical Practice Guideline

A. Davis, V. Bramwell, R. Bell, 2002, Sarcoma.

Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study.

M. van Glabbeke, D. Machin, M. Nooij, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metastatic Secondary Fibrosarcoma of Bone Responsive to Repeated Courses of Ifosfamide and Associated With Hypoglycemia

V. Bramwell, N. Rodger, E. Bouttell, 2003, Sarcoma.

Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.

G. Demetri, E. Ette, V. Bramwell, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.

L. Trani, M. van Glabbeke, M. Sydes, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical Study A Phase II Study of Flavopiridol in Patients With Previously Untreated Advanced Soft Tissue Sarcoma

E. Eisenhauer, V. Bramwell, M. Blackstein, 2014 .

A Phase II Study of Flavopiridol in Patients With Previously Untreated Advanced Soft Tissue Sarcoma

E. Eisenhauer, V. Bramwell, M. Blackstein, 2006, Sarcoma.

Safety and Efficacy of the Multidrug-Resistance Inhibitor Biricodar ( VX-710 ) with Concurrent Doxorubicin in Patients with Anthracycline-resistant Advanced Soft Tissue Sarcoma 1

G. Demetri, E. Ette, V. Bramwell, 2002 .

The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer.

L. Stitt, F. O'Malley, V. Bramwell, 1996, Human pathology.

Soft Tissue Sarcoma Surveillance Counterpoint: Canada

V. Bramwell, L. Mack, 2013 .

Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

J. Hirsh, M. Gent, V. Bramwell, 1994, The Lancet.

The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation.

M. Gent, V. Bramwell, H. Abu-Zahra, 1992, British Journal of Cancer.

A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.

M. Gent, V. Bramwell, H. Abu-Zahra, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy.

I. Andrulis, F. O'Malley, D. Tu, 2009, Journal of the National Cancer Institute.

Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EBC).

L. Murphy, P. Watson, D. Tu, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.

A. Craft, P. Voûte, A. V. van Oosterom, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow involvement in adult soft tissue sarcomas.

J. Chang, D. Crowther, V. Bramwell, 1982, European journal of cancer & clinical oncology.

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

J. Verweij, S. Bonvalot, F. van Coevorden, 2012, The Lancet. Oncology.

Contribution of Osteopontin to the Development of Bone Metastasis

V. Bramwell, A. Chambers, T. Vandenberg, 2005 .

Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patients

V. Bramwell, N. Thatcher, H. Anderson, 1987, International journal of cancer.

Phase II intergroup study of sorafenib (S) in advanced soft tissue sarcomas (STS): SWOG 0505

J. Goldblum, G. Demetri, C. Rankin, 2008 .

Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer.

E. Perez, K. Gelmon, H. Rugo, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.

J W Oosterhuis, J Verweij, M. van Glabbeke, 2001, European journal of cancer.

Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.

J. Blay, M. van Glabbeke, P. Hohenberger, 2013, European journal of cancer.

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study.

M. Nooij, M. Glabbeke, A. Craft, 2005, European journal of cancer.

Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.

Dongsheng Tu, Nancy Paul, D. Tu, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.

D. Tu, V. Bramwell, B. Norris, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group.

J. Mulder, L. Bastholt, A. Santoro, 1987, European journal of cancer & clinical oncology.

A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer.

V. Bramwell, K. Pritchard, H. Abu-Zahra, 1992, European journal of cancer.

Processes and Outcomes of Care for Soft Tissue Sarcoma of the Extremities

B. O'Sullivan, W. Mackillop, V. Bramwell, 2002, Sarcoma.

Pazopanib and the treatment palette for soft-tissue sarcoma

V. Bramwell, 2012, The Lancet.

Current perspectives in the management of soft-tissue sarcoma. The role of chemotherapy in multimodality therapy.

V. Bramwell, 1988, Canadian journal of surgery. Journal canadien de chirurgie.

Controversies in Surgical Oncology: Routine Anthracycline-based Adjuvant Chemotherapy for Stage III Extremity Soft Tissue Sarcoma

V. Bramwell, 2007, Annals of Surgical Oncology.

Review of the clinical trials activity of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research and Treatment of Cancer.

J. Mulder, A. Santoro, H. Mouridsen, 1988, Seminars in surgical oncology.

The role of chemotherapy in osteogenic sarcoma.

V. Bramwell, 1995, Critical reviews in oncology/hematology.

Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Bramwell, R. Sylvester, P. Voûte, 1985, Cancer treatment reports.

E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma.

R. Sylvester, H. Mouridsen, A. V. van Oosterom, 1979, European journal of cancer.

VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group.

A. Santoro, H. Mouridsen, V. Bramwell, 1987, European journal of cancer & clinical oncology.

Mitomycin C (MCC) in advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.

R. Sylvester, A. Santoro, H. Mouridsen, 1985, European journal of cancer & clinical oncology.

Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials Group.

E. Eisenhauer, M. Knowling, V. Bramwell, 1989, Journal of the National Cancer Institute.

Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases

F. O'Malley, V. Bramwell, A. Chambers, 1998, The Lancet.

Timing of surgery influences survival in receptor-negative as well as receptor-positive breast cancer.

V. Bramwell, B. Garcia, L. Stitt, 1994, European journal of cancer.

High-dose continuous venous infusion of interleukin-2: Influence of dose and infusion rate on tumoricidal function and lymphocyte subsets

L. Stitt, V. Bramwell, D. Banerjee, 1995, Cancer Immunology, Immunotherapy.

Phase II study of amsacrine in refractory lymphomas. A report of the EORTC Early Clinical Trials Group.

M. van Glabbeke, V. Bramwell, W. W. ten Bokkel Huinink, 1984, European journal of cancer & clinical oncology.

Metastatic Osteosarcoma: A Review of Current Issues in Systemic Treatment

V. Bramwell, 1997, Sarcoma.

Quality of life in stage II breast cancer: an instrument for clinical trials.

G. Guyatt, G. Guyatt, M. Gent, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): Pooled analysis of the two STBSG-EORTC phase III clinical trials

J. Blay, M. Glabbeke, A. Cesne, 2008 .

High-Dose Chemotherapy Followed by Peripheral and/or Bone Marrow Stem Cell Transplant in Patients With Advanced Sarcoma: Experience of a Canadian Centre.

V. Bramwell, S. Hotte, K. Howson‐Jan, 2004 .

High-Dose Chemotherapy Followed by Peripheral and/or Bone Marrow Stem Cell Transplant in Patients With Advanced Sarcoma: Experience of a Canadian Centre

V. Bramwell, S. Hotte, K. Howson‐Jan, 2004, Sarcoma.

Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.

W. Parulekar, V. Bramwell, K. Pritchard, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials

T. Whelan, K. Gelmon, F. O'Malley, 2013, Breast Cancer Research and Treatment.

Do authors of review articles use systematic methods to identify, assess and synthesize information?

V. Bramwell, C. Williams, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group.

N. Boyd, J. Ragaz, M. Knowling, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial

D. Huntsman, I. Andrulis, F. O'Malley, 2011, Breast Cancer Research and Treatment.

A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12).

D. Tu, V. Bramwell, K. Pritchard, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic and predictive value of topoisomerase II alpha in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5).

D. Huntsman, I. Andrulis, F. O'Malley, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial

V. Bramwell, A. Chambers, Lei Han, 2014, Breast Cancer Research.

A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial

E. Eisenhauer, J. Dancey, M. Knowling, 2006, Investigational New Drugs.

Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study

E. Eisenhauer, V. Bramwell, A. Paterson, 1988, Investigational New Drugs.

Adjuvant Chemotherapy in the Treatment of Soft‐Tissue Sarcoma

V. Bramwell, W. Mertens, 1993, Clinical orthopaedics and related research.

The place of chemotherapy in the management of soft tissue sarcoma: experiences of the EORTC Soft Tissue and Bone Sarcoma Group.

J. Verweij, A. Santoro, H. Mouridsen, 1989, Clinical oncology (Royal College of Radiologists (Great Britain)).

Adjuvant chemotherapy for soft tissue sarcomas.

V. Bramwell, V H Bramwell, 1989, Cancer treatment and research.

Carcinomatous meningitis associated with infiltrating lobular carcinoma of the breast.

A. Howell, V. Bramwell, R. Sellwood, 1985, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Dose effect of imatinib (IM) in patients (pts) with metastatic GIST - Phase III Sarcoma Group Study S0033.

J. Crowley, G. Demetri, C. Blanke, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Canadian Experience with Intensive Fluorouracil, Epirubicin and Cyclophosphamide in Patients with Early Stage Breast Cancer

V. Bramwell, K. Pritchard, M. Levine, 2012, Drugs.

Dibromodulcitol, mitomycin C and vinblastine (DMV) chemotherapy in advanced breast cancer.

A. Howell, V. Bramwell, I. J. Moneypenny, 1984, European journal of cancer & clinical oncology.

A Phase II Study of Docetaxel in Chemotherapy-Naïve Patients With Recurrent or Metastatic Adult Soft Tissue Sarcoma

K. Bélanger, E. Eisenhauer, V. Bramwell, 1998, Sarcoma.

Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.

V. Bramwell, L. Moran, L. Seymour, 1999, Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC.

Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases

Jason L. Townson, G. Naumov, V. Bramwell, 2003, Breast Cancer Research and Treatment.

Statistical Classification Strategy for Proton Magnetic Resonance Spectra of Soft Tissue Sarcoma: An Exploratory Study with Potential Clinical Utility

Rakesh Patel, Ray L. Somorjai, R. Somorjai, 2002, Sarcoma.

European experience of adjuvant chemotherapy for soft tissue sarcoma: Preliminary report of randomized trial of cyclophosphamide, vincristine, doxorubicin, and dacarbazine

A. Santoro, V. Bramwell, J. Rouessé, 1985 .

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials

T. Whelan, K. Gelmon, J. Ingle, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Treating Breast Cancer

J. Cuzick, J. Forbes, X. Bonfill, 2003 .

Caution with breast-conserving surgery.

V. Bramwell, T. Vandenberg, 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Repeated investigations of cyclophosphamide disposition in myeloma patients receiving intermittent chemotherapy.

V. Bramwell, R. Calvert, G. Edwards, 1980, British Journal of Clinical Pharmacology.

Chemotherapy for metastatic soft tissue sarcomas--another full circle?

V. Bramwell, 1991, British Journal of Cancer.

Adjuvant chemotherapy for soft tissue sarcomas.

V. Bramwell, W. Mertens, 1991, Cancer treatment and research.

Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group.

A. Santoro, H. Mouridsen, A. V. van Oosterom, 1984, Cancer treatment reports.